AVANOS MEDICAL, INC. Stockholders Equity

Quick Answer

AVANOS MEDICAL, INC. reported Stockholders Equity of $778.20 million for the year ending 2025.

  • AVANOS MEDICAL, INC. showed a decrease of -6.1% in Stockholders Equity from 2024 to 2025.
  • This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
  • XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q3 2014: $2.08 billion | Q1 2015: $1.51 billion | Q2 2015: $1.52 billion | Q3 2015: $1.04 billion | Q1 2016: $1.08 billion | Q2 2016: $1.09 billion | Q3 2016: $1.10 billion | Q1 2017: $1.13 billion | Q2 2017: $1.16 billion | Q3 2017: $1.18 billion | Q1 2018: $1.25 billion | Q2 2018: $1.29 billion | Q3 2018: $1.30 billion | Q1 2019: $1.28 billion | Q2 2019: $1.28 billion | Q3 2019: $1.27 billion | Q1 2020: $1.26 billion | Q2 2020: $1.26 billion | Q3 2020: $1.29 billion | Q1 2021: $1.26 billion | Q2 2021: $1.30 billion | Q3 2021: $1.27 billion | Q1 2022: $1.26 billion | Q2 2022: $1.26 billion | Q3 2022: $1.26 billion | Q1 2023: $1.30 billion | Q2 2023: $1.23 billion | Q3 2023: $1.22 billion | Q1 2024: $1.23 billion | Q2 2024: $1.22 billion | Q3 2024: $1.23 billion | Q1 2025: $839.40 million | Q2 2025: $776.30 million | Q3 2025: $778.00 million.
  • Over the full 15 years of available data (2011 to 2025), AVANOS MEDICAL, INC.'s Stockholders Equity has declined by 61.0%.
  • Historical annual values: Fiscal year 2025: $778.20 million | Fiscal year 2024: $828.50 million | Fiscal year 2023: $1.24 billion | Fiscal year 2022: $1.29 billion | Fiscal year 2021: $1.27 billion | Fiscal year 2020: $1.26 billion | Fiscal year 2019: $1.27 billion | Fiscal year 2018: $1.30 billion | Fiscal year 2017: $1.22 billion | Fiscal year 2016: $1.10 billion | Fiscal year 2015: $1.06 billion | Fiscal year 2014: $1.49 billion | Fiscal year 2013: $2.08 billion | Fiscal year 2012: $2.06 billion | Fiscal year 2011: $2.00 billion.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: